Featured, Mass Torts Update - Written by Jere Beasley on Thursday, February 5, 2009 9:42 - 0 Comments

FDA Is Still Probing Safety Of Singulair

Tags: ,

SingulairIt was reported last month that federal health officials are still conducting a months-long investigation into possible links between asthma drugs, including Merck’s Singulair, and suicide. In March, the Food and Drug Administration said it was reviewing a handful of reports involving mood changes, suicidal behavior and suicide in patients who had taken Singulair. But, over nine months later, the agency now says it still has not reached a conclusion and will continue its investigation of Singulair and similar drugs. First approved in 1998, Singulair was Merck’s best-selling product last year. The company expects to report between $4.3 and $4.5 billion in sales of the drug for 2008. It is part of a class of drugs that includes AstraZeneca PLC’s Accolate and Critical TherapeuticsInc.’s Zyflo.

Source: Associated Press




Leave a Reply

Comment

Comments are moderated and generally will be posted if they are on-topic and not abusive.

Powered by WP Hashcash

Personal Injury, Recent Settlements - Jul 19, 2010 14:03 - 0 Comments

Wrongful Death Settlement In Civil Damages Act

More In Recent Settlements


Product Liability - Jul 31, 2010 15:21 - 0 Comments

Reclining Seats Are A Hidden Danger

More In Product Liability


Recalls Update - Aug 19, 2010 12:24 - 0 Comments

Prescription Cat Food Recalled

More In Recalls Update